The Global Industrial Biomanufacturing Market 2027-2037

0

Industrial biomanufacturing uses living systems to produce molecules that would otherwise come from petrochemical feedstocks or natural extraction. The industrial biomanufacturing market spans six commercial domains — biopharmaceuticals, industrial enzymes, biofuels, bioplastics, biochemicals, and bio-agritech — and its economic case rests on three arguments that are becoming more compelling simultaneously. Decarbonisation: biological production routes displace fossil feedstocks across chemicals, fuels, materials, and food ingredients, and where carbon pricing tightens the cost gap narrows structurally rather than cyclically. Supply chain resilience: fermentation can be sited close to demand and run on local or waste-derived carbon. And strategic autonomy: the United States BIOSECURE Act of December 2025 and its National Security Commission on Emerging Biotechnology have identified limited domestic biomanufacturing scale-up capacity as a national security vulnerability.

The industrial biomanufacturing market’s record warrants honest assessment alongside the opportunity. Between 2019 and 2026, POET halted cellulosic production at Project Liberty, Clariant closed its Podari plant and exited biofuels, Fulcrum BioEnergy and Red Rock Biofuels entered bankruptcy, and Viridos filed for Chapter 11 after ExxonMobil ended a $350 million algae programme. No commercial biomass gasification-Fischer-Tropsch plant operates anywhere. Announced capacity consistently exceeds realised capacity. This report presents forecasts that are explicitly contingent on scale-up that has repeatedly proven harder than projected — a transparency that differentiates it from the promotional optimism that has characterised much industrial biomanufacturing market analysis.

Industrial Biomanufacturing Market Report 2027-2037 — Key Coverage Areas

  • Biopharmaceutical Manufacturing — monoclonal antibody production, mRNA therapeutic manufacturing, gene therapy vector production, and vaccine manufacturing using mammalian, microbial, and cell-free biological systems; GMP requirements; and the strategic shift toward domestic biopharmaceutical manufacturing under BIOSECURE Act provisions
  • Industrial Enzymes — engineered enzyme production for detergent, textile, food processing, animal feed, and pulp and paper applications; directed evolution and AI-accelerated enzyme design; and the commercial enzyme producer competitive landscape including Novozymes, DSM-Firmenich, and BASF
  • Advanced Biofuels — cellulosic ethanol, renewable diesel, sustainable aviation fuel, and bio-based marine fuel production using biological conversion of lignocellulosic feedstocks; the technology track record including failures and successes; and the current commercial operating plant landscape
  • Bioplastics and Bio-based Polymers — PLA, PHA, and bio-based monomer production via fermentation; the commercial production volumes and cost trajectories; and the regulatory drivers creating demand for bio-based polymer feedstocks
  • Biochemicals and Platform Chemicals — succinic acid, lactic acid, itaconic acid, adipic acid, and 1,4-butanediol biological production; cost competitiveness versus petrochemical routes; and the commercial production status by molecule
  • Bio-agritech — biological nitrogen fixation, microbial biostimulants, biocontrol agents, and biofertilisers replacing synthetic agricultural inputs; the regulatory landscape for biological crop input approvals; and the commercial adoption trajectory
  • 1,000+ Company Profiles — comprehensive profiles across all six industrial biomanufacturing domains covering technology, funding, production capacity, and commercial status
  • 10-Year Forecasts — industrial biomanufacturing market value by domain, production technology, and region from 2027 through 2037 with explicit scenario analysis reflecting historical scale-up failure rates

The industrial biomanufacturing market report is the most honest and comprehensive analysis of this sector available — essential reading for investors, corporate strategists, and technology developers who need the full picture including the risks.

Ideal for biotech investors, specialty chemical companies, pharmaceutical manufacturers, energy companies, and corporate sustainability teams.

cover

cover

  • Published: August 2026
  • Pages: 635
  • Tables: 312
  • Figures: 41

 

Industrial biomanufacturing uses living systems — microbes, mammalian, plant and insect cells, and increasingly cell-free enzymatic platforms — to produce molecules that would otherwise be made from petrochemical feedstocks or extracted from natural sources. It spans six commercial domains: biopharmaceuticals, industrial enzymes, biofuels, bioplastics, biochemicals and bio-agritech. The sector's economic case rests on three arguments rather than one. The first is decarbonisation: biological routes displace fossil feedstocks across chemicals, fuels, materials and food ingredients, and where carbon pricing tightens the cost gap narrows structurally rather than cyclically. The second is supply-chain resilience, since fermentation can be sited close to demand and run on local or waste-derived carbon. This has become explicit policy: the United States enacted the BIOSECURE Act in December 2025 and its National Security Commission on Emerging Biotechnology has identified limited domestic scale-up capacity as a structural weakness, while China has published target product lists to direct investment. The third is value capture — biomanufacturing creates new industrial ecosystems in strain design, bioprocess engineering and downstream separation rather than merely substituting inputs.

Biopharmaceuticals remain the largest value pool, with an addressable market approaching $1 trillion by 2030 across monoclonal antibodies, vaccines, recombinant proteins and the faster-growing cell, gene and RNA therapeutic segments. Industrial enzymes represent a mature multi-billion dollar market. Biofuels are the largest volume segment, and bioplastics, biochemicals and bio-agritech expanding from smaller bases. The technology frontier is moving on several fronts simultaneously: AI-driven protein and pathway design compressing design-build-test cycles; continuous and intensified fermentation displacing batch operation; cell-free systems removing the constraints of cell viability; and alternative feedstocks — C1 gases, lignocellulosics and captured CO₂ — reducing dependence on food crops.

The sector's record also warrants caution. Between 2019 and 2026 POET halted cellulosic production at Project Liberty, Clariant closed its Podari plant and exited biofuels, Fulcrum BioEnergy and Red Rock Biofuels entered bankruptcy without completing commercial production, both Enerkem sites failed, and Viridos filed for Chapter 11 after ExxonMobil ended a $350 million algae programme. No commercial biomass gasification-Fischer-Tropsch plant operates anywhere. Announced capacity consistently exceeds realised capacity, and forecasts should be read as contingent on a scale-up that has repeatedly proven harder than projected.

The Global Industrial Biomanufacturing Market 2027-2037 provides a comprehensive assessment of industrial biomanufacturing across its six commercial domains, combining technology analysis, market forecasts to 2037 and profiles of more than 1,000 companies. Industrial biomanufacturing has moved from a substitution play to a matter of industrial strategy, driven by decarbonisation targets, supply-chain security concerns and the emergence of AI-enabled biological design. This report examines what is genuinely commercial, what remains pre-commercial, and where announced capacity has failed to materialise. Coverage begins with production platforms — microbial fermentation, mammalian, plant and insect cell culture, transgenic systems and cell-free biomanufacturing — before addressing enabling technologies including synthetic biology, CRISPR-based strain engineering, continuous and intensified processing, downstream separation, and AI and robotics in bioprocess design.

Six market chapters then assess biopharmaceuticals, industrial enzymes, biofuels, bioplastics, biochemicals and bio-agritech. Each covers technology and materials analysis, market drivers, regulations, value chain, technology readiness, addressable market size, risks and opportunities, and global revenue forecasts segmented by product type, application and region. The report includes revenue and volume forecasts to 2037, capacity and consumption series for renewable diesel, biodiesel, bio-jet fuel, bioethanol, biomethane and bio-LNG, and detailed assessments of feedstock availability including waste lipids, lignocellulosics, C1 and C2 gases, and captured CO₂. More than 1,080 companies are profiled with descriptions, country of operation and website. 

Contents

  • Executive Summary — definition and scope, processes, key components, economic importance, colours of biotechnology, markets, AI and robotics, emerging technologies
  • Production — microbial fermentation, mammalian cell culture, plant cell culture, insect cell culture, transgenic animals and plants, technologies, scale, mode of operation, host organisms
  • Biopharmaceuticals — overview, technology analysis, market analysis, company profiles
  • Industrial Enzymes (Biocatalysts) — overview, technology analysis, market analysis, company profiles
  • Biofuels — overview, technology analysis, market analysis, company profiles
  • Bioplastics — overview, technology analysis, market analysis, company profiles
  • Biochemicals — overview, technology analysis, market analysis, company profiles
  • Bio-Agritech — overview, technology analysis, market analysis, company profiles

 

Companies profiled include 3Bar Biologics, 3DBioFibR, 3M, 9Fiber, Inc., AbbVie, Absci Corp, Adaptive Symbiotic Technologies, ADBioplastics, Adjuvants Plus, Adriano di Marti/Desserto, Aduro Clean Technologies, Inc., Advanced Biochemical (Thailand) Co., Ltd., Aemetis, Inc., AEP Polymers, Aeropowder Limited, AFINGEN®, Afyren, AGAE Technologies LLC, Again Bio, AgBiome, Agilyx, Agra Energy, Agragene, AGRANA Staerke GmbH, Agrinos, Agrivida, Agrobiomics, AgroRenew, AgroSpheres, Ahlstrom-Munksjö Oyj, AI Proteins, Air Company, Aircela Inc, Alexion Pharmaceuticals, Algaeing, Algal Bio Co., Ltd., Algenesis Corporation, Algenie, Algenl, Algenol, Alginor ASA, Algix LLC, Allied Carbon Solutions, Allozymes, Alnylam Pharmaceuticals, Alpha Biofuels (Singapore) Pte Ltd, Alto Neuroscience, AM Green, Amano Enzyme Inc., Amatera, Amfora, Amgen, AmicaTerra, Aminoverse, Amphista Therapeutics, AmphiStar, Amply Discovery, AMSilk GmbH, An Phát Bioplastics, Ananas Anam Ltd., Andermatt Biocontrol, Andritz AG, Anellotech, Inc., Ankor Bioplastics Co., Ltd., Anodyne Chemistries, ANPOLY, Inc., Anqing He Xing Chemical Co., Ltd., Ansa Biotechnologies, Antheia, APChemi Pvt. Ltd., Apeiron Bioenergy, Aperam BioEnergia, Apexzymes, Aphea.Bio, Applied Bioplastics, Applied Research Associates, Inc. (ARA), Aqemia, Aquafil S.p.A., Aquapak Polymers Ltd, Arcadia Biosciences, Arcadia eFuels, Archer Daniel Midland Company (ADM), Arctic Biomaterials Oy, Ardra Bio, Arekapak GmbH, Arkema S.A, Arlanxeo, Arrow Greentech, Arysta LifeScience, Arzeda, Arzeda Corp., Asahi Kasei Chemicals Corporation, ASB Biodiesel Limited, Ascribe Bioscience, AstraZeneca, Atantares, Athos Therapeutics, Atlántica Agrícola, Atmonia, Atomwise, Attis Innovations, llc, Aurigene Pharmaceutical Services, AVA Biochem AG, Avalon BioEnergy, Avani Eco, Avantium B.V., Avicenna Biosciences, Avient Corporation, Avioxx, Axcelon Biopolymers Corporation, Ayas Renewables Inc., Azolla, Azotic Technologies, B-PREG, Balrampur Chini Mills, Bambooder Biobased Fibers B.V., Basecamp Research, BASF, BASF SE, Bast Fiber Technologies, Inc., Bayer CropScience, BBCA Biochemical & GALACTIC Lactic Acid Co., Ltd., Bcomp ltd., BDI-BioEnergy International GmbH, BEE Biofuel, Bee Vectoring Technologies, BeiGene, Benefuel Inc., BenevolentAI, Better Fibre Technologies, Betulium Oy, Beyond Leather Materials ApS, BigHat Biosciences, BigSis, Bio Fab NZ, BIO-FED, BIO-LUTIONS International AG, Bio-Oils, Bio2Materials Sp. z o.o., Bio2Oil ApS, BioAge Labs, Biobest, BioBetter, Biocatalysts Ltd., Bioceres Crop Solutions, Biocon, BioConsortia, BIOD Energy, BioEnz Technologies, Bioextrax AB, Biofiber Tech Sweden AB, Biofibre GmbH, Biofine Technology, LLC, Bioform Technologies, Biofy, BiogasClean A/S, Biogen, Biojet AS, Biokemik, Bioleather, Biolevel, Biolexis Therapeutics, Bioline AgroSciences, BIOLO, BioLogiQ, Inc., BioMap, Biomass Resin Holdings Co., Ltd., Biomatter, Biomatter Designs, Biome Bioplastics, Biome Makers, Bionema, BioNTech, BioPhero, Biophilica, BioPhy, Bioplastech Ltd, Bioplastix, Biopolax, Bioptimus SAS, BioSolutions, Biosyntia, Biotalys, BIOTEC GmbH & Co. KG, Biotecam, Biotechnology SL, Biotelliga, Biotensidion GmbH, Biotic Circular Technologies Ltd., Biotrem, Biotrop, Biovox, Bioweg, bitBiome, BlockTexx Pty Ltd., Bloom Biorenewables SA, BluCon Biotech GmbH, Blue BioFuels, Inc., Blue Ocean Closures, BlueAlp Technology, Bluepha Beijing Lanjing Microbiology Technology Co., Ltd., Bolt Threads, Bontera, Boreal Bioproducts, Borealis AG, Borregaard Chemcell, Bosk Bioproducts Inc., Botanical Solutions, Bowil Biotech Sp. z o.o., Braskem SA, Braven Environmental, LLC, Brightmark Energy, Brightseed, Bristol Myers Squibb, bse Methanol GmbH, BTG Bioliquids B.V., Bucha Bio, Inc., Burgo Group S.p.A., Buyo Bioplastic Ltd., Byogy Renewables, Inc., B’ZEOS, C-Zero Inc., C1 Green Chemicals AG, C16 Biosciences, Cambrium GmbH, Caphenia GmbH, CARAPAC Company, Carapace Biopolymers, Carbiolice, Carbios, Carbon Collect Limited, Carbon Crusher, Carbon Engineering Ltd., Carbon Infinity Limited, Carbon Recycling International, Carbon Sink LLC, Carbonade, CarbonBridge, Carbonwave, Carbyon BV, Cardia Bioplastics Ltd., Cardolite, Cargill, Cascade Biocatalysts, Cascade Biocatalysts, Inc., Cass Materials Pty Ltd, Cassandra Oil AB, Casterra Ag Ltd., Catalyxx, Cathay Industrial Biotech, Ltd., Celanese Corporation, Cellicon B.V., CellON, Celltrion, Cellucomp Ltd., Celluforce, Cellugy, Cellutech AB (Stora Enso), Celtic Renewables Ltd., Century Health Technology, Inc., Ceradis, Cereal Process Technologies (CPT), CERT Systems, Inc., Certis USA, CF Industries Holdings, Inc., CH-Bioforce Oy, ChainCraft, ChakraTech, Checkerspot, Inc., Chempolis Oy, Chestnut Bio Polymers, ChiralVision B.V., Chitelix, Chitose Bio Evolution Pte Ltd., Chongqing Bofei Biochemical Products Co., Ltd., Chuetsu Pulp & Paper Co., Ltd., Cibus, CIMV, CinderBio, Circa Group, Circla Nordic, Circular Systems, CJ Biomaterials, Inc., Clariant, Clariant AG, CleanJoule, Climeworks, CNF Biofuel AS, CO2BioClean, Coastgrass ApS, Codexis, COFCO Cooperation Ltd., Coffeeco Upcycle, Conagen, Concentric Agriculture, Concord Blue Engineering, Constructive Bio, Cool Planet Energy Systems, Corn Next, Corsair Group International, Corteva Agriscience, Corumat, Inc. and more....

 

 

 

 

 

 

 

 

1             EXECUTIVE SUMMARY            29

  • 1.1        Definition and Scope of Industrial Biomanufacturing        29
  • 1.2        Overview of Industrial Biomanufacturing Processes           30
  • 1.3        Key Components of Industrial Biomanufacturing 32
  • 1.4        Importance of Industrial Biomanufacturing in the Global Economy          33
  • 1.5        Colours of Biotechnology      33
  • 1.6        Markets              34
    • 1.6.1    Biopharmaceuticals 34
    • 1.6.2    Industrial Enzymes    35
    • 1.6.3    Biofuels             35
    • 1.6.4    Biomaterials and Bioplastics              36
    • 1.6.5    Specialty Chemicals 37
    • 1.6.6    Food and Beverage    37
    • 1.6.7    Agriculture and Animal Health           38
    • 1.6.8    Environmental Biotechnology             39
  • 1.7        AI and Robotics in Biomanufacturing            40
  • 1.8        Other Advanced and Emerging Technologies in Biomanufacturing           41

 

2             PRODUCTION               43

  • 2.1        Microbial Fermentation           43
  • 2.2        Mammalian Cell Culture        43
  • 2.3        Plant Cell Culture        44
  • 2.4        Insect Cell Culture     44
    • 2.4.1    Overview           44
    • 2.4.2    Cell lines           45
    • 2.4.3    Process characteristics          45
    • 2.4.4    Glycosylation 45
    • 2.4.5    Commercial applications      45
    • 2.4.6    Position within industrial biomanufacturing             46
  • 2.5        Transgenic Animals   46
  • 2.6        Transgenic Plants        47
  • 2.7        Technologies  47
    • 2.7.1    Upstream Processing               47
      • 2.7.1.1 Cell Culture     47
        • 2.7.1.1.1           Overview           47
        • 2.7.1.1.2           Types of Cell Culture Systems            47
        • 2.7.1.1.3           Factors Affecting Cell Culture Performance              48
        • 2.7.1.1.4           Advances in Cell Culture Technology             49
          • 2.7.1.1.4.1      Single-use systems   49
          • 2.7.1.1.4.2      Process analytical technology (PAT)               49
          • 2.7.1.1.4.3      Cell line development              49
    • 2.7.2    Fermentation 50
      • 2.7.2.1 Overview           50
        • 2.7.2.1.1           Types of Fermentation Processes    50
        • 2.7.2.1.2           Factors Affecting Fermentation Performance          50
        • 2.7.2.1.3           Advances in Fermentation Technology         51
          • 2.7.2.1.3.1      High-cell-density fermentation          51
          • 2.7.2.1.3.2      Continuous processing           51
          • 2.7.2.1.3.3      Metabolic engineering             52
          • 2.7.2.1.3.4      Synthetic biology applications           52
          • 2.7.2.1.3.5      Cell-free systems        52
          • 2.7.2.1.3.6      Continuous vs batch biomanufacturing      53
    • 2.7.3    Downstream Processing        54
      • 2.7.3.1 Purification      54
        • 2.7.3.1.1           Overview           54
        • 2.7.3.1.2           Types of Purification Methods            54
        • 2.7.3.1.3           Factors Affecting Purification Performance               54
        • 2.7.3.1.4           Advances in Purification Technology              55
          • 2.7.3.1.4.1      Affinity chromatography         55
          • 2.7.3.1.4.2      Membrane chromatography 55
          • 2.7.3.1.4.3      Continuous chromatography              56
          • 2.7.3.1.4.4      Downstream processing (DSP) improvements        56
          • 2.7.3.1.4.5      Tangential flow filtration (TFF) in downstream bioprocessing        57
    • 2.7.4    Formulation    58
      • 2.7.4.1 Overview           58
        • 2.7.4.1.1           Types of Formulation Methods           58
        • 2.7.4.1.2           Factors Affecting Formulation Performance             58
        • 2.7.4.1.3           Advances in Formulation Technology            59
          • 2.7.4.1.3.1      Controlled release      59
          • 2.7.4.1.3.2      Nanoparticle formulation      59
          • 2.7.4.1.3.3      3D printing       59
    • 2.7.5    Bioprocess Development      59
      • 2.7.5.1 Scale-up            59
        • 2.7.5.1.1           Overview           59
        • 2.7.5.1.2           Factors Affecting Scale-up Performance     60
        • 2.7.5.1.3           Scale-up Strategies    61
      • 2.7.5.2 Optimization  61
        • 2.7.5.2.1           Overview           61
        • 2.7.5.2.2           Factors Affecting Optimization Performance            61
        • 2.7.5.2.3           Optimization Strategies           62
        • 2.7.5.2.4           Machine learning to improve biomanufacturing processes            63
        • 2.7.5.2.5           Process intensification and high-cell-density fermentation           65
        • 2.7.5.2.6           Hybrid biotechnological-chemical approaches     67
    • 2.7.6    Analytical Methods    69
      • 2.7.6.1 Quality Control             69
        • 2.7.6.1.1           Overview           69
        • 2.7.6.1.2           Types of Quality Control Tests            69
        • 2.7.6.1.3           Factors Affecting Quality Control Performance      71
      • 2.7.6.2 Characterization          71
        • 2.7.6.2.1           Overview           71
        • 2.7.6.2.2           Types of Characterization Methods 72
        • 2.7.6.2.3           Factors Affecting Characterization Performance   73
    • 2.7.7    Synthetic Biology Tools and Techniques      74
      • 2.7.7.1 DNA synthesis              74
      • 2.7.7.2 CRISPR-Cas9 systems            75
      • 2.7.7.3 Protein/enzyme engineering 75
      • 2.7.7.4 Computer-aided design          76
      • 2.7.7.5 Strain construction and optimization            77
      • 2.7.7.6 Robotics and automation      78
      • 2.7.7.7 Artificial intelligence and machine learning              79
    • 2.7.8    Alternative Feedstocks and Sustainability 80
      • 2.7.8.1 C1 feedstocks: Metabolic pathways               80
      • 2.7.8.2 C2 feedstocks               81
      • 2.7.8.3 Lignocellulosic biomass feedstocks              82
      • 2.7.8.4 Blue biotechnology feedstocks         83
      • 2.7.8.5 Routes for carbon capture in biotechnology             84
  • 2.8        Scale of Production   85
    • 2.8.1    Laboratory Scale         85
      • 2.8.1.1 Overview           85
      • 2.8.1.2 Scale and Equipment               85
      • 2.8.1.3 Advantages     86
      • 2.8.1.4 Disadvantages             86
    • 2.8.2    Pilot Scale        87
      • 2.8.2.1 Overview           87
      • 2.8.2.2 Scale and Equipment               87
      • 2.8.2.3 Advantages     87
      • 2.8.2.4 Disadvantages             88
    • 2.8.3    Commercial Scale      88
      • 2.8.3.1 Overview           88
      • 2.8.3.2 Scale and Equipment               88
      • 2.8.3.3 Advantages     89
      • 2.8.3.4 Disadvantages             90
  • 2.9        Mode of Operation     90
    • 2.9.1    Batch Production        90
      • 2.9.1.1 Overview           90
      • 2.9.1.2 Advantages     91
      • 2.9.1.3 Disadvantages             91
      • 2.9.1.4 Applications   92
    • 2.9.2    Fed-batch Production              92
      • 2.9.2.1 Overview           92
      • 2.9.2.2 Advantages     92
      • 2.9.2.3 Disadvantages             93
      • 2.9.2.4 Applications   93
    • 2.9.3    Continuous Production           93
      • 2.9.3.1 Overview           93
      • 2.9.3.2 Advantages     93
      • 2.9.3.3 Disadvantages             94
      • 2.9.3.4 Applications   94
      • 2.9.3.5 Key fermentation parameter comparison   94
    • 2.9.4    Downstream processing and product recovery       96
    • 2.9.5    Cell factories for biomanufacturing 96
      • 2.9.5.1 Range of organisms  98
      • 2.9.5.2 Escherichia coli (E.coli)           99
      • 2.9.5.3 Corynebacterium glutamicum (C. glutamicum)     100
      • 2.9.5.4 Bacillus subtilis (B. subtilis) 101
      • 2.9.5.5 Saccharomyces cerevisiae (S. cerevisiae)  101
      • 2.9.5.6 Yarrowia lipolytica (Y. lipolytica)        102
      • 2.9.5.7 Non-model organisms            103
    • 2.9.6    Perfusion Culture        104
      • 2.9.6.1 Overview           104
      • 2.9.6.2 Advantages     104
      • 2.9.6.3 Disadvantages             105
      • 2.9.6.4 Applications   105
      • 2.9.6.5 Perfusion bioreactors               105
    • 2.9.7    Other Modes of Operation     106
      • 2.9.7.1 Immobilized Cell Culture       106
        • 2.9.7.1.1           Immobilized enzymes              107
        • 2.9.7.1.2           Immobilized catalysts              108
      • 2.9.7.2 Two-Stage Production              109
      • 2.9.7.3 Hybrid Systems            109
  • 2.10     Host Organisms          110
    • 2.10.1 Genetic stability and containment  111
  • 2.11     Manufacturing capacity and contract production 112
  • 2.12     Scale-up economics and the first-of-a-kind problem         112
  • 2.13     Sustainability accounting and certification                113
  • 2.14     Water and resource intensity              113

 

3             BIOPHARMACEUTICALS        115

  • 3.1        Overview           115
  • 3.2        Technology/materials analysis          115
    • 3.2.1    Monoclonal Antibodies (mAbs)         115
    • 3.2.2    Recombinant Proteins             116
    • 3.2.3    Vaccines           116
    • 3.2.4    Cell and Gene Therapies        117
    • 3.2.5    Blood Factors 118
    • 3.2.6    Tissue Engineering Products                118
    • 3.2.7    Nucleic Acid Therapeutics    119
    • 3.2.8    Peptide Therapeutics               119
    • 3.2.9    Biosimilars and Biobetters    120
    • 3.2.10 Nanobodies and Antibody Fragments           121
    • 3.2.11 Synthetic biology         121
      • 3.2.11.1            Metabolic engineering             122
        • 3.2.11.1.1        DNA synthesis              122
        • 3.2.11.1.2        CRISPR              123
          • 3.2.11.1.2.1   CRISPR/Cas9-modified biosynthetic pathways      123
      • 3.2.11.2            Protein/Enzyme Engineering                124
      • 3.2.11.3            Strain construction and optimization            125
      • 3.2.11.4            Synthetic biology and metabolic engineering           126
      • 3.2.11.5            Smart bioprocessing 126
      • 3.2.11.6            Cell-free systems        127
      • 3.2.11.7            Chassis organisms    129
      • 3.2.11.8            Biomimetics   130
      • 3.2.11.9            Sustainable materials              131
      • 3.2.11.10         Robotics and automation      131
        • 3.2.11.10.1     Robotic cloud laboratories   132
        • 3.2.11.10.2     Automating organism design              132
        • 3.2.11.10.3     Artificial intelligence and machine learning              132
      • 3.2.11.11         Fermentation Processes        133
    • 3.2.12 Generative Biology     133
      • 3.2.12.1            Generative Adversarial Networks (GANs)    135
        • 3.2.12.1.1        Variational Autoencoders (VAEs)      135
        • 3.2.12.1.2        Normalizing Flows      135
        • 3.2.12.1.3        Autoregressive Models            135
        • 3.2.12.1.4        Evolutionary Generative Models       136
      • 3.2.12.2            Design Optimization 136
        • 3.2.12.2.1        Evolutionary Algorithms (e.g., Genetic Algorithms, Evolutionary Strategies)       136
          • 3.2.12.2.1.1   Genetic Algorithms (GAs)      136
          • 3.2.12.2.1.2   Evolutionary Strategies (ES) 136
        • 3.2.12.2.2        Reinforcement Learning         137
        • 3.2.12.2.3        Multi-Objective Optimization              137
        • 3.2.12.2.4        Bayesian Optimization            137
      • 3.2.12.3            Computational Biology           138
        • 3.2.12.3.1        Molecular Dynamics Simulations    138
        • 3.2.12.3.2        Quantum Mechanical Calculations                139
        • 3.2.12.3.3        Systems Biology Modeling    139
        • 3.2.12.3.4        Metabolic Engineering Modeling       140
      • 3.2.12.4            Data-Driven Approaches       140
        • 3.2.12.4.1        Machine Learning       141
        • 3.2.12.4.2        Graph Neural Networks           141
        • 3.2.12.4.3        Unsupervised Learning           141
        • 3.2.12.4.4        Active Learning and Bayesian Optimization              142
      • 3.2.12.5            Agent-Based Modeling            142
      • 3.2.12.6            Hybrid Approaches    143
    • 3.2.13 Antibody-drug conjugates and multispecific formats         144
    • 3.2.14 Continuous and intensified biologics manufacturing         145
  • 3.3        Market analysis            145
    • 3.3.1    Key players and competitive landscape      145
    • 3.3.2    Market Growth Drivers and Trends   146
    • 3.3.3    Regulations     147
    • 3.3.4    Value chain     149
    • 3.3.5    Future outlook              149
    • 3.3.6    Technology Readiness Level (TRL)   150
    • 3.3.7    Addressable Market Size        151
    • 3.3.8    Risks and Opportunities         151
    • 3.3.9    Global revenues           153
      • 3.3.9.1 By application market              153
      • 3.3.9.2 By regional market      154
  • 3.4        Company profiles       156

 

4             INDUSTRIAL ENZYMES (BIOCATALYSTS)      182

  • 4.1        Overview           182
    • 4.1.1    Bio-manufactured enzymes 182
  • 4.2        Technology/materials analysis          183
    • 4.2.1    Detergent Enzymes    183
    • 4.2.2    Food Processing Enzymes    184
    • 4.2.3    Textile Processing Enzymes  184
    • 4.2.4    Paper and Pulp Processing Enzymes             185
    • 4.2.5    Leather Processing Enzymes               185
    • 4.2.6    Biofuel Production Enzymes                186
      • 4.2.6.1 Enzymes for lignocellulosic derived bioethanol      186
      • 4.2.6.2 Cellulases for lignocellulosic bioethanol    187
      • 4.2.6.3 Hemicellulases and synergistic enzyme cocktails                188
      • 4.2.6.4 Thermostable and extremophilic enzymes 189
      • 4.2.6.5 Cost-performance metrics for thermostable enzymes      190
    • 4.2.7    Animal Feed Enzymes              191
    • 4.2.8    Pharmaceutical and Diagnostic Enzymes  192
    • 4.2.9    Waste Management and Bioremediation Enzymes              192
      • 4.2.9.1 Enzymes for plastics recycling           193
      • 4.2.9.2 Enzymatic depolymerization               194
      • 4.2.9.3 Challenges in enzymatic depolymerization               195
    • 4.2.10 Agriculture and Crop Improvement Enzymes           195
    • 4.2.11 Enzymes for Decarbonization and CO₂ Utilization 197
      • 4.2.11.1            Carbonic anhydrase in CO₂ capture technologies 199
      • 4.2.11.2            Formate dehydrogenase and CO₂-to-chemicals pathways             200
      • 4.2.11.3            Selected enzymatic approaches to CO2 capture and conversion              201
    • 4.2.12 Enzyme immobilisation          203
  • 4.3        Market analysis            204
    • 4.3.1    Key players and competitive landscape      204
    • 4.3.2    Market Growth Drivers and Trends   205
    • 4.3.3    Technology challenges and opportunities for industrial enzymes               206
    • 4.3.4    Economic competitiveness of enzymatic processing         207
    • 4.3.5    Regulations     208
    • 4.3.6    Value chain     209
    • 4.3.7    Future outlook              209
    • 4.3.8    Technology Readiness Level (TRL)   211
    • 4.3.9    Addressable Market Size        211
    • 4.3.10 Risks and Opportunities         212
    • 4.3.11 Global revenues           212
      • 4.3.11.1            By application market              212
      • 4.3.11.2            By regional market      214
  • 4.4        Company profiles       215

 

5             BIOFUELS        231

  • 5.1        Overview           231
  • 5.2        Technology/materials analysis          233
    • 5.2.1    Role in the circular economy               233
    • 5.2.2    The global biofuels market    235
    • 5.2.3    Feedstocks      235
      • 5.2.3.1 First-generation (1-G)               236
      • 5.2.3.2 Second-generation (2-G)       237
        • 5.2.3.2.1           Lignocellulosic wastes and residues             238
        • 5.2.3.2.2           Biorefinery lignin         240
      • 5.2.3.3 Third-generation (3-G)             244
        • 5.2.3.3.1           Algal biofuels 244
          • 5.2.3.3.1.1      Properties         245
          • 5.2.3.3.1.2      Advantages     245
      • 5.2.3.4 Fourth-generation (4-G)          246
      • 5.2.3.5 Advantages and disadvantages, by generation        247
    • 5.2.4    Bioethanol       248
      • 5.2.4.1 First-generation bioethanol (from sugars and starches)    248
      • 5.2.4.2 Second-generation bioethanol (from lignocellulosic biomass)   248
      • 5.2.4.3 Third-generation bioethanol (from algae)    249
    • 5.2.5    Biodiesel           249
      • 5.2.5.1 Biodiesel by generation           249
      • 5.2.5.2 Production of biodiesel and other biofuels 250
        • 5.2.5.2.1           Pyrolysis of biomass 251
        • 5.2.5.2.2           Vegetable oil transesterification       254
        • 5.2.5.2.3           Vegetable oil hydrogenation (HVO)  255
          • 5.2.5.2.3.1      Production process   255
        • 5.2.5.2.4           Biodiesel from tall oil                257
        • 5.2.5.2.5           Fischer-Tropsch BioDiesel     257
        • 5.2.5.2.6           Hydrothermal liquefaction of biomass         260
        • 5.2.5.2.7           CO2 capture and Fischer-Tropsch (FT)          260
        • 5.2.5.2.8           Dymethyl ether (DME)              261
      • 5.2.5.3 Prices  261
      • 5.2.5.4 Global production and consumption            262
    • 5.2.6    Biogas 263
      • 5.2.6.1 Feedstocks      265
      • 5.2.6.2 Biomethane    266
        • 5.2.6.2.1           Production pathways                268
          • 5.2.6.2.1.1      Landfill gas recovery 268
          • 5.2.6.2.1.2      Anaerobic digestion  268
          • 5.2.6.2.1.3      Thermal gasification 269
      • 5.2.6.3 Global production      270
      • 5.2.6.4 Prices  270
        • 5.2.6.4.1           Raw Biogas     270
        • 5.2.6.4.2           Upgraded Biomethane            271
      • 5.2.6.5 Bio-LNG             271
        • 5.2.6.5.1           Markets              271
          • 5.2.6.5.1.1      Trucks 271
          • 5.2.6.5.1.2      Marine 271
        • 5.2.6.5.2           Plants 271
      • 5.2.6.6 bio-CNG (compressed natural gas derived from biogas)  272
      • 5.2.6.7 Carbon capture from biogas               272
      • 5.2.6.8 Biosyngas        273
        • 5.2.6.8.1           Production       273
        • 5.2.6.8.2           Prices  274
    • 5.2.7    Biobutanol      274
      • 5.2.7.1 Production       276
      • 5.2.7.2 Prices  276
    • 5.2.8    Biohydrogen   277
      • 5.2.8.1 Description     277
        • 5.2.8.1.1           Dark fermentation      277
        • 5.2.8.1.2           Photofermentation     278
        • 5.2.8.1.3           Biophotolysis (direct and indirect)   278
          • 5.2.8.1.3.1      Direct Biophotolysis: 278
          • 5.2.8.1.3.2      Indirect Biophotolysis:            279
      • 5.2.8.2 Production of biohydrogen from biomass  280
        • 5.2.8.2.1           Biological Conversion Routes             280
          • 5.2.8.2.1.1      Bio-photochemical Reaction              280
          • 5.2.8.2.1.2      Fermentation and Anaerobic Digestion        281
        • 5.2.8.2.2           Thermochemical conversion routes               281
          • 5.2.8.2.2.1      Biomass Gasification               281
          • 5.2.8.2.2.2      Biomass Pyrolysis      281
          • 5.2.8.2.2.3      Biomethane Reforming           282
      • 5.2.8.3 Applications   282
      • 5.2.8.4 Prices  283
    • 5.2.9    Biomethanol  283
      • 5.2.9.1 Gasification-based biomethanol     283
      • 5.2.9.2 Biosynthesis-based biomethanol    284
      • 5.2.9.3 Methanol-to gasoline technology     284
        • 5.2.9.3.1           Production processes              285
          • 5.2.9.3.1.1      Anaerobic digestion  286
          • 5.2.9.3.1.2      Biomass gasification 286
          • 5.2.9.3.1.3      Power to Methane       287
    • 5.2.10 Bio-oil and Biochar    287
      • 5.2.10.1            Pyrolysis-based bio-oil            288
      • 5.2.10.2            Hydrothermal liquefaction-based bio-oil    288
      • 5.2.10.3            Biochar from pyrolysis and gasification processes               289
      • 5.2.10.4            Advantages of bio-oils             290
      • 5.2.10.5            Production       292
        • 5.2.10.5.1        Fast Pyrolysis 292
        • 5.2.10.5.2        Costs of production  292
        • 5.2.10.5.3        Upgrading        292
      • 5.2.10.6            Applications   293
      • 5.2.10.7            Bio-oil producers         294
      • 5.2.10.8            Prices  294
        • 5.2.10.8.1        Biochar co-product economics         295
        • 5.2.10.8.2        Biochar in anaerobic digestion          296
    • 5.2.11 Renewable Diesel and Jet Fuel           296
      • 5.2.11.1            Renewable diesel        296
        • 5.2.11.1.1        Production       296
        • 5.2.11.1.2        Global consumption 297
        • 5.2.11.1.3        Prices  298
      • 5.2.11.2            Bio-aviation fuel (bio-jet fuel, sustainable aviation fuel, renewable jet fuel or aviation biofuel)              298
        • 5.2.11.2.1        Description     298
        • 5.2.11.2.2        SWOT analysis              300
        • 5.2.11.2.3        Global production and consumption            301
        • 5.2.11.2.4        Production pathways                301
        • 5.2.11.2.5        Prices  302
        • 5.2.11.2.6        Bio-aviation fuel production capacities       303
        • 5.2.11.2.7        Challenges      303
        • 5.2.11.2.8        Global consumption 304
    • 5.2.12 Algal biofuels 304
      • 5.2.12.1            Conversion pathways               304
      • 5.2.12.2            SWOT analysis              305
      • 5.2.12.3            Production       306
      • 5.2.12.4            Market challenges      307
      • 5.2.12.5            Prices  308
      • 5.2.12.6            Producers         309
    • 5.2.13 Power-to-liquids and e-fuels                309
      • 5.2.13.1            The regulatory driver  310
    • 5.2.14 Marine fuels    310
      • 5.2.14.1            Comparison with biological pathways          311
  • 5.3        Market analysis            312
    • 5.3.1    Key players and competitive landscape      312
    • 5.3.2    Market Growth Drivers and Trends   314
    • 5.3.3    Regulations     315
    • 5.3.4    Value chain     316
    • 5.3.5    Future outlook              317
    • 5.3.6    Technology Readiness Level (TRL)   318
    • 5.3.7    Addressable Market Size        320
    • 5.3.8    Risks and Opportunities         320
    • 5.3.9    Global revenues           321
      • 5.3.9.1 By biofuel type               321
      • 5.3.9.2 Applications Market  322
      • 5.3.9.3 By regional market      323
  • 5.4        Company profiles       325

 

6             BIOPLASTICS 363

  • 6.1        Overview           363
  • 6.2        Technology/materials analysis          364
    • 6.2.1    Polylactic acid (PLA) 364
    • 6.2.2    Polyhydroxyalkanoates (PHAs)          366
      • 6.2.2.1 Types   367
      • 6.2.2.2 Polyhydroxybutyrate (PHB)   371
      • 6.2.2.3 Polyhydroxyvalerate (PHV)    371
    • 6.2.3    Bio-based polyethylene (PE)                372
    • 6.2.4    Bio-based polyethylene terephthalate (PET)             373
    • 6.2.5    Bio-based polyurethanes (PUs)         374
    • 6.2.6    Starch-based plastics              375
    • 6.2.7    Cellulose-based plastics       376
    • 6.2.8    End-of-life pathways and recycling interaction       377
  • 6.3        Market analysis            377
    • 6.3.1    Key players and competitive landscape      377
    • 6.3.2    Market Growth Drivers and Trends   379
    • 6.3.3    Regulations     380
    • 6.3.4    Value chain     381
    • 6.3.5    Future outlook              382
    • 6.3.6    Technology Readiness Level (TRL)   383
    • 6.3.7    Addressable Market Size        385
    • 6.3.8    Risks and Opportunities         385
    • 6.3.9    Global revenues           386
      • 6.3.9.1 By type                386
      • 6.3.9.2 By application market              387
      • 6.3.9.3 By regional market      388
  • 6.4        Company profiles       390

 

7             BIOCHEMICALS           463

  • 7.1        Overview           463
  • 7.2        Bio-based feedstocks              464
    • 7.2.1    Organic acids 468
      • 7.2.1.1 Lactic acid       468
        • 7.2.1.1.1           D-lactic acid   468
        • 7.2.1.1.2           L-lactic acid    468
      • 7.2.1.2 Succinic acid 469
      • 7.2.1.3 Itaconic acid  470
      • 7.2.1.4 Citric acid        471
      • 7.2.1.5 Acetic acid      472
      • 7.2.1.6 Malonic acid   472
    • 7.2.2    Amino acids   473
      • 7.2.2.1 Glutamic acid                473
      • 7.2.2.2 Lysine 473
      • 7.2.2.3 Threonine         475
      • 7.2.2.4 Methionine      475
      • 7.2.2.5 Vitamins produced using biotechnology     476
        • 7.2.2.5.1           Vitamin B2 (Riboflavin)            477
        • 7.2.2.5.2           Vitamin B12 (Cobalamin)      477
        • 7.2.2.5.3           Vitamin C (Ascorbic Acid)      478
        • 7.2.2.5.4           Vitamin B7 (Biotin)     479
        • 7.2.2.5.5           Vitamin B3 (Niacin  Nicotinic Acid)  479
        • 7.2.2.5.6           Vitamin B9 (Folic Acid  Folate)            480
    • 7.2.3    Alcohols            481
      • 7.2.3.1 Ethanol              481
      • 7.2.3.2 Butanol              481
      • 7.2.3.3 Isobutanol       482
      • 7.2.3.4 Propanediol    483
    • 7.2.4    Surfactants     484
      • 7.2.4.1 Biosurfactants (e.g., rhamnolipids, sophorolipids)              484
        • 7.2.4.1.1           Rhamnolipids 485
        • 7.2.4.1.2           Sophorolipids                486
        • 7.2.4.1.3           Mannosylerythritol lipids (MELs)      487
        • 7.2.4.1.4           Cellobiose lipids          488
        • 7.2.4.1.5           Designer glycolipids and lipopeptides via synthetic biology           489
      • 7.2.4.2 Alkyl polyglucosides (APGs) 490
    • 7.2.5    Solvents            491
      • 7.2.5.1 Ethyl lactate    491
      • 7.2.5.2 Dimethyl carbonate   491
      • 7.2.5.3 Glycerol             492
    • 7.2.6    Flavours and fragrances         492
      • 7.2.6.1 Vanillin               492
      • 7.2.6.2 Nootkatone     493
      • 7.2.6.3 Limonene         494
      • 7.2.6.4 Bio-manufactured fragrances and aromatics          496
      • 7.2.6.5 Biotech-derived fragrance precursors           496
      • 7.2.6.6 Ambroxan        497
      • 7.2.6.7 Flavour enhancers      498
      • 7.2.6.8 Disodium Inosinate (IMP)      499
      • 7.2.6.9 Disodium Guanylate (GMP)  500
      • 7.2.6.10            Monatin             501
    • 7.2.7    Bio-based monomers and intermediates    501
      • 7.2.7.1 Succinic acid 501
      • 7.2.7.2 1,4-Butanediol (BDO)              502
      • 7.2.7.3 Isoprene            504
      • 7.2.7.4 Ethylene            504
      • 7.2.7.5 Propylene         505
      • 7.2.7.6 Adipic acid      506
      • 7.2.7.7 Acrylic acid     507
      • 7.2.7.8 Sebacic acid  508
      • 7.2.7.9 C12: Dodecanedioic acid (DDDA)    509
      • 7.2.7.10            1,5-Pentanediamine (PDA)   509
    • 7.2.8    Bio-based polymers  509
      • 7.2.8.1 Polybutylene succinate (PBS)             509
      • 7.2.8.2 Polyamides (nylons)  511
      • 7.2.8.3 Polyethylene furanoate (PEF)              511
      • 7.2.8.4 Polytrimethylene terephthalate (PTT)            512
      • 7.2.8.5 Polyethylene isosorbide terephthalate (PEIT)           514
        • 7.2.8.5.1           Overview           514
        • 7.2.8.5.2           Applications   515
    • 7.2.9    Bio-based composites and blends  515
      • 7.2.9.1 Wood-plastic composites (WPCs)  515
      • 7.2.9.2 Biofiller-reinforced plastics  516
      • 7.2.9.3 Biofiber-reinforced plastics  517
      • 7.2.9.4 Polymer blends with bio-based components           518
    • 7.2.10 Beauty and Personal Care Chemicals           519
      • 7.2.10.1            Hyaluronic acid production  519
      • 7.2.10.2            Squalene and Squalane alternatives              520
      • 7.2.10.3            Collagen           521
      • 7.2.10.4            Bio-based UV filters and photoprotective compounds      522
      • 7.2.10.5            Melanin             523
      • 7.2.10.6            Emollients       524
    • 7.2.11 Waste 525
      • 7.2.11.1            Food waste      525
      • 7.2.11.2            Agricultural waste       526
      • 7.2.11.3            Forestry waste               527
      • 7.2.11.4            Aquaculturefishing waste      527
      • 7.2.11.5            Municipal solid waste              528
      • 7.2.11.6            Industrial waste           528
      • 7.2.11.7            Waste oils        528
    • 7.2.12 Microbial and mineral sources           529
      • 7.2.12.1            Microalgae      529
      • 7.2.12.2            Macroalgae     529
      • 7.2.12.3            Cyanobacteria              530
      • 7.2.12.4            Mineral sources            531
    • 7.2.13 Precision fermentation and alternative proteins    532
    • 7.2.14 Other Bio-manufactured Products  533
      • 7.2.14.1            Cement alternatives from biomanufacturing           533
      • 7.2.14.2            Precision fermentation products      535
  • 7.3        Market analysis            536
    • 7.3.1    Key players and competitive landscape      536
      • 7.3.1.1 Company landscape in specialty chemicals biotechnology          538
      • 7.3.1.2 Bio-manufactured beauty ingredient production capacities          538
    • 7.3.2    Market Growth Drivers and Trends   541
      • 7.3.2.1 Trends and drivers in biotechnology               542
      • 7.3.2.2 Government support of biotechnology         542
      • 7.3.2.3 Carbon taxes  545
    • 7.3.3    Regulations     546
    • 7.3.4    Value chain     547
      • 7.3.4.1 Economic viability factors     548
      • 7.3.4.2 Effect of feedstock prices      549
      • 7.3.4.3 Scale-up effects on cost        550
    • 7.3.5    Future outlook              551
    • 7.3.6    Technology Readiness Level (TRL)   552
    • 7.3.7    Addressable Market Size        553
    • 7.3.8    Risks and Opportunities         554
    • 7.3.9    Major market challenges        554
    • 7.3.10 Technical challenges 555
    • 7.3.11 Global revenues           556
      • 7.3.11.1            By type                556
      • 7.3.11.2            By application market              557
      • 7.3.11.3            By regional market      558
  • 7.4        Company profiles       560

 

8             BIO-AGRITECH             579

  • 8.1        Overview           579
  • 8.2        Technology & materials analysis      580
    • 8.2.1    Biopesticides 580
      • 8.2.1.1 Semiochemical            581
      • 8.2.1.2 Macrobial Biological Control Agents              581
      • 8.2.1.3 Microbial pesticides  584
      • 8.2.1.4 Biochemical pesticides          584
      • 8.2.1.5 Plant-incorporated protectants (PIPs)           585
    • 8.2.2    Biofertilizers   586
    • 8.2.3    Biostimulants 587
      • 8.2.3.1 Microbial biostimulants         587
        • 8.2.3.1.1           Nitrogen Fixation         589
        • 8.2.3.1.2           Formulation Challenges         590
      • 8.2.3.2 Natural Product Biostimulants          590
      • 8.2.3.3 Manipulating the Microbiome             593
      • 8.2.3.4 Synthetic Biology        594
      • 8.2.3.5 Non-microbial biostimulants             595
    • 8.2.4    Agricultural Enzymes                596
      • 8.2.4.1 Types of Agricultural Enzymes            596
    • 8.2.5    RNA-based biopesticides and semiochemicals     598
  • 8.3        Market analysis            599
    • 8.3.1    Key players and competitive landscape      599
    • 8.3.2    Market Growth Drivers and Trends   600
    • 8.3.3    Regulations     601
    • 8.3.4    Value chain     602
    • 8.3.5    Future outlook              602
    • 8.3.6    Addressable Market Size        603
    • 8.3.7    Risks and Opportunities         604
    • 8.3.8    Global revenues           604
      • 8.3.8.1 By application market              604
      • 8.3.8.2 By regional market      605
  • 8.4        Company profiles       607

 

9             RESEARCH METHODOLOGY              627

 

10          REFERENCES 628

 

 

List of Tables

  • Table 1. Biomanufacturing revolutions and representative products.      29
  • Table 2. Industrial Biomanufacturing categories.  30
  • Table 3. Overview of Biomanufacturing Processes.             31
  • Table 4. Continuous vs batch biomanufacturing   32
  • Table 5. Key Components of Industrial Biomanufacturing.             33
  • Table 6. Colours of biotechnology.  34
  • Table 7. AI and Robotics Applications in Biomanufacturing           40
  • Table 8. Advanced Technologies in Biomanufacturing Applications.       42
  • Table 9. Types of Cell Culture Systems.       48
  • Table 10. Factors Affecting Cell Culture Performance.      49
  • Table 11. Types of Fermentation Processes.             50
  • Table 12. Factors Affecting Fermentation Performance.   51
  • Table 13. Advances in Fermentation Technology.   51
  • Table 14. Continuous vs Batch Biomanufacturing Comparison. 53
  • Table 15. Types of Purification Methods in Downstream Processing.       54
  • Table 16. Factors Affecting Purification Performance.        54
  • Table 17. Advances in Purification Technology.       55
  • Table 18. Downstream Processing Technology Improvements.    57
  • Table 19. TFF Applications in Downstream Processing.    57
  • Table 20. Common formulation methods used in biomanufacturing.     58
  • Table 21. Factors Affecting Formulation Performance.      58
  • Table 22. Advances in Formulation Technology.     59
  • Table 23. Factors Affecting Scale-up Performance in Biomanufacturing.             60
  • Table 24. Scale-up Strategies in Biomanufacturing.            61
  • Table 25. Factors Affecting Optimization Performance in Biomanufacturing.    62
  • Table 26. Optimization Strategies in Biomanufacturing.   62
  • Table 27. Machine Learning Applications in Biomanufacturing   64
  • Table 28. High-Cell-Density Fermentation Parameters and Targets.         65
  • Table 29. Hybrid Biotechnological-Chemical Process Applications.        67
  • Table 30. Types of Quality Control Tests in Biomanufacturing.     69
  • Table 31. Factors Affecting Quality Control Performance in Biomanufacturing 71
  • Table 32. Types of Characterization Methods in Biomanufacturing.         72
  • Table 33. Factors Affecting Characterization Performance in Biomanufacturing             73
  • Table 34. DNA Synthesis Technologies and Capabilities. 74
  • Table 35. CRISPR-Cas9 Applications in Biomanufacturing.           75
  • Table 36. Protein Engineering Strategies and Applications.             76
  • Table 37. Computer-Aided Design Tools in Biotechnology.              77
  • Table 38. Strain Engineering Strategies and Targets.            78
  • Table 39. Automation Applications in Biotechnology.         79
  • Table 40. AI/ML Applications in Biomanufacturing Systems.         80
  • Table 41. C1 Feedstock Utilization Pathways and Characteristics.            81
  • Table 42. C2 Feedstock Processing and Applications.       81
  • Table 43. Lignocellulosic Biomass Processing Technologies.        82
  • Table 44. Blue Biotechnology Feedstock Characteristics and Applications.       83
  • Table 45. Carbon Capture and Utilization Pathways in Biotechnology.   85
  • Table 46. Key fermentation parameters in batch vs continuous biomanufacturing processes.              91
  • Table 47. Key fermentation parameter comparison             94
  • Table 48. Downstream processing cost share by product class   96
  • Table 49. Major microbial cell factories used in industrial biomanufacturing.   97
  • Table 50. Organism Categories and Production Capabilities.       98
  • Table 51. E. coli Characteristics for Biomanufacturing Applications.      99
  • Table 52. C. glutamicum Production Capabilities and Characteristics.  100
  • Table 53. B. subtilis Production Systems and Applications.           101
  • Table 54. S. cerevisiae Capabilities and Industrial Applications. 102
  • Table 55. Y. lipolytica Production Capabilities and Process Parameters.               103
  • Table 56. Non-Model Organisms and Specialized Applications. 104
  • Table 57. Perfusion Bioreactor Technologies and Performance.  106
  • Table 58. Enzyme Immobilization Methods and Characteristics. 107
  • Table 59. Immobilized Catalyst Systems and Applications.            108
  • Table 60. Comparison of Modes of Operation.        109
  • Table 61. Host organisms commonly used in biomanufacturing.               110
  • Table 62. Types of biopharmaceuticals.      115
  • Table 63. Types of Monoclonal Antibodies. 116
  • Table 64. Types of Recombinant Proteins.  116
  • Table 65. Types of biopharma vaccines.      117
  • Table 66. Types of Cell and Gene Therapies              117
  • Table 67. Types of Blood Factors.     118
  • Table 68. Types of Tissue Engineering Products.     118
  • Table 69. Types of Nucleic Acid Therapeutics.         119
  • Table 70. Types of Peptide Therapeutics.    120
  • Table 71. Types of Biosimilars and Biobetters.         120
  • Table 72. Types of Nanobodies and Antibody Fragments. 121
  • Table 73. Types of Synthetic Biology Applications in Biopharmaceuticals.          121
  • Table 74. Engineered proteins in industrial applications. 125
  • Table 75. Cell-free versus cell-based systems         128
  • Table 76. White biotechnology fermentation processes.  133
  • Table 77. Key players in biopharmaceuticals.          145
  • Table 78. Market Growth Drivers and Trends in Biopharmaceuticals.      146
  • Table 79. Biopharmaceuticals Regulations.              147
  • Table 80. Value chain: Biopharmaceuticals.            149
  • Table 81. Technology Readiness Level (TRL): Biopharmaceuticals.          150
  • Table 82. Addressable market size for biopharmaceuticals.          151
  • Table 83. Risks and Opportunities in biopharmaceuticals.             151
  • Table 84. Global revenues for biopharmaceuticals, by applications market (2020-2037), billions USD.                153
  • Table 85. Global revenues for biopharmaceuticals, by regional market (2020-2037), billions USD.    154
  • Table 86. Biopharmaceuticals company profiles. 156
  • Table 87. Types of industrial enzymes.          182
  • Table 88. Types of Detergent Enzymes.        183
  • Table 89. Types of Food Processing Enzymes           184
  • Table 90. Types of Textile Processing Enzymes.      184
  • Table 91. Types of Paper and Pulp Processing Enzymes.  185
  • Table 92. Types of Leather Processing Enzymes.   185
  • Table 93. Types of Biofuel Production Enzymes.     186
  • Table 94. Lignocellulosic Enzyme Systems and Performance.      187
  • Table 95. Cellulase Component Functions and Characteristics. 188
  • Table 96. Hemicellulase Systems and Substrate Specificity.         189
  • Table 97. Thermostable Enzyme Sources and Characteristics.    190
  • Table 98. Thermostable Enzyme Economic Analysis Framework.               191
  • Table 99. Types of Animal Feed Enzymes.   191
  • Table 100. Types of Pharmaceutical and Diagnostic Enzymes.    192
  • Table 101. Types of Waste Management and Bioremediation Enzymes. 192
  • Table 102. Enzymes for Plastics Recycling Applications.  194
  • Table 103. Challenges in Enzymatic Depolymerization.     195
  • Table 104. Types of Agriculture and Crop Improvement Enzymes.             196
  • Table 105. Comparison of enzyme types.    196
  • Table 106. Enzymes for Decarbonization and CO₂ Utilization.      198
  • Table 107. Carbonic Anhydrase Applications in CO₂ Capture.      200
  • Table 108. Formate Dehydrogenase Systems for CO₂ Conversion.            201
  • Table 109. Enzymatic approaches to CO₂ capture and conversion            202
  • Table 110. Enzymatic CO₂ Capture and Conversion Technologies.            203
  • Table 111. Key players in industrial enzymes.          204
  • Table 112. Market Growth Drivers and Trends in industrial enzymes.       205
  • Table 113. Technology Challenges and Opportunities for Industrial Enzymes.  206
  • Table 114. Industrial enzymes Regulations.              208
  • Table 115. Value chain: Industrial enzymes.             209
  • Table 116. Technology Readiness Level (TRL): Biocatalysts.          211
  • Table 117. Addressable market size for industrial enzymes.          211
  • Table 118. Risks and Opportunities in industrial enzymes.             212
  • Table 119. Global revenues for industrial enzymes, by applications market (2020-2037), billions USD.                213
  • Table 120. Global revenues for industrial enzymes, by regional market (2020-2037), billions USD.     214
  • Table 121. Industrial Enzymes Company Profiles. 215
  • Table 122. Types of biofuel, by generation. 231
  • Table 123. Comparison of biofuels. 234
  • Table 124. Classification of biomass feedstock.    235
  • Table 125. Biorefinery feedstocks.   236
  • Table 126. Feedstock conversion pathways.             236
  • Table 127. First-Generation Feedstocks.     236
  • Table 128. Lignocellulosic ethanol plants and capacities.              239
  • Table 129. Comparison of pulping and biorefinery lignins.              240
  • Table 130. Commercial and pre-commercial biorefinery lignin production facilities and processes  240
  • Table 131. Operating and planned lignocellulosic biorefineries and industrial flue gas-to-ethanol.   242
  • Table 132. Properties of microalgae and macroalgae.       245
  • Table 133. Yield of algae and other biodiesel crops.            246
  • Table 134. Advantages and disadvantages of biofuels, by generation.    247
  • Table 135. Biodiesel by generation. 249
  • Table 136. Biodiesel production techniques.            250
  • Table 137. Summary of pyrolysis technique under different operating conditions.         251
  • Table 138. Biomass materials and their bio-oil yield.          253
  • Table 139. Biofuel production cost from the biomass pyrolysis process.              254
  • Table 140. Properties of vegetable oils in comparison to diesel.  255
  • Table 141. Main producers of HVO and capacities.              256
  • Table 142. Commercial development of BtL processes     258
  • Table 143. Pilot or demo projects for biomass to liquid (BtL) processes.               259
  • Table 144.Biodiesel (B20) average prices, current and historical, USD/litre.        261
  • Table 145. Global biodiesel consumption, 2010–2037 (M litres/year)      262
  • Table 146. Biogas and biomethane feedstock          265
  • Table 147. Existing and planned bio-LNG production plants.        271
  • Table 148. Methods for capturing carbon dioxide from biogas.    272
  • Table 149. Total syngas market by product 273
  • Table 150. Biosyngas price ranges by application: 274
  • Table 151. Comparison of different Bio-H2 production pathways.             280
  • Table 152. Markets and applications for biohydrogen.       282
  • Table 153. Comparison of biogas, biomethane and natural gas. 285
  • Table 154. Summary of applications of biochar in energy.               290
  • Table 155. Typical composition and physicochemical properties reported for bio-oils and heavy petroleum-derived oils.          291
  • Table 156. Properties and characteristics of pyrolysis liquids derived from biomass versus a fuel oil.                291
  • Table 157. Main techniques used to upgrade bio-oil into higher-quality fuels.   293
  • Table 158. Markets and applications for bio-oil.     293
  • Table 159. Bio-oil producers.              294
  • Table 160. Global renewable diesel consumption, 2010-2037 (M litres/year).   297
  • Table 161. Renewable diesel price ranges  298
  • Table 162. Advantages and disadvantages of Bio-aviation fuel.   299
  • Table 163. Production pathways for Bio-aviation fuel.        302
  • Table 164. Current and announced Bio-aviation fuel facilities and capacities. 303
  • Table 165. Global bio-jet fuel consumption, 2019–2037 (million litres/year)       304
  • Table 166. production cost estimates and projections      308
  • Table 167. Algae-derived biofuel producers.             309
  • Table 168. Comparison with biological pathways  311
  • Table 169. Power-to-liquids and e-fuels Companies           311
  • Table 170. Key players in biofuels.   313
  • Table 171. Market Growth Drivers and Trends in biofuels.               314
  • Table 172. Biofuels Regulations.       315
  • Table 173. Value chain: Biofuels.      316
  • Table 174. Technology Readiness Level (TRL): Biofuels.   318
  • Table 175. Addressable market size, billions USD 320
  • Table 176. Risks and Opportunities in biofuels       320
  • Table 177. Global revenues for biofuels, by type (2020-2037), billions USD.       321
  • Table 178. Global Revenues for Biofuels, by Applications Market (2020-2037), billions USD. 322
  • Table 179. Global revenues for biofuels, by regional market (2020-2037), billions USD.             323
  • Table 180. Biofuels Company Profiles.         325
  • Table 181. Types of bioplastics:        363
  • Table 182. Polylactic acid (PLA) market analysis-manufacture, advantages, disadvantages and applications.  365
  • Table 183. Types of PHAs and properties.   368
  • Table 184. Commercially available PHAs.  369
  • Table 185. Markets and applications for PHAs.       370
  • Table 186. Bio-based Polyethylene (Bio-PE) market analysis- manufacture, advantages, disadvantages and       372
  • Table 187. Bio-based Polyethylene terephthalate (Bio-PET) market analysis- manufacture, advantages,                373
  • Table 188. Bio-based Polyethylene terephthalate (PET) producers and production capacities               374
  • Table 189. Key players in Bioplastics.            378
  • Table 190. Market Growth Drivers and Trends in Bioplastics.        379
  • Table 191. Bioplastics Market Restraints and counter-trends        380
  • Table 192. Bioplastics Regulations. 380
  • Table 193. Value chain: Bioplastics.               381
  • Table 194. Technology Readiness Level (TRL): Bioplastics.            383
  • Table 195. Addressable market size for Bioplastics (Values in billions USD)       385
  • Table 196. Risks and Opportunities in Bioplastics.              385
  • Table 197. Global revenues for bioplastics, by type (2020-2037), billions USD. 386
  • Table 198. Global revenues for bioplastics, by applications market (2020-2037), billions USD.            387
  • Table 199. Global revenues for bioplastics, by regional market (2020-2037), billions USD.      388
  • Table 200. Bioplastics Company Profiles.  390
  • Table 201. Types of biochemicals.   463
  • Table 202. Plant-based feedstocks and biochemicals produced.               464
  • Table 203. Waste-based feedstocks and biochemicals produced.            465
  • Table 204. Microbial and mineral-based feedstocks and biochemicals produced.         466
  • Table 205. Biobased feedstock sources for Succinic acid.              469
  • Table 206. Applications of succinic acid.    470
  • Table 207. Biobased feedstock sources for itaconic acid.               470
  • Table 208. Applications of bio-based itaconic acid.            471
  • Table 209. Feedstock Sources for Citric Acid Production.               471
  • Table 210. Applications of Citric Acid.           471
  • Table 211. Feedstock Sources for Acetic Acid Production.             472
  • Table 212. Applications of Acetic Acid.         472
  • Table 213. Feedstock Sources for Acetic Acid Production.             473
  • Table 214. Applications of Acetic Acid.         473
  • Table 215. Common lysine sources that can be used as feedstocks for producing biochemicals.      474
  • Table 216. Applications of lysine as a feedstock for biochemicals.           474
  • Table 217. Feedstock Sources for Threonine Production. 475
  • Table 218. Applications of Threonine.           475
  • Table 219. Feedstock Sources for Methionine Production.             475
  • Table 220. Applications of Methionine.        476
  • Table 221. Vitamins Produced Using Biotechnology.          476
  • Table 222. Biobased feedstock sources for ethanol.           481
  • Table 223. Applications of bio-based ethanol.        481
  • Table 224. Feedstock Sources for Butanol Production.     482
  • Table 225. Applications of Butanol. 482
  • Table 226. Biobased feedstock sources for isobutanol.    482
  • Table 227. Applications of bio-based isobutanol. 483
  • Table 228. Applications of bio-based 1,3-Propanediol (1,3-PDO).             483
  • Table 229. Types of Biosurfactants. 484
  • Table 230. Feedstock Sources for Biosurfactant Production          484
  • Table 231. Applications of Biosurfactants  484
  • Table 232. Rhamnolipid Production and Application Characteristics.     485
  • Table 233. Sophorolipid Types and Application Properties.             487
  • Table 234. Mannosylerythritol Lipid Variants and Properties.        488
  • Table 235. Cellobiose Lipid Development and Applications.         488
  • Table 236. Designer Biosurfactant Engineering Strategies               490
  • Table 237. Feedstock Sources for APG Production               490
  • Table 238. Applications of Alkyl Polyglucosides (APGs)     490
  • Table 239. Feedstock Sources for Ethyl Lactate Production.         491
  • Table 240. Applications of Ethyl Lactate.     491
  • Table 241. Feedstock Sources for Dimethyl Carbonate Production           491
  • Table 242. Applications of Dimethyl Carbonate      492
  • Table 243. Markets and applications for bio-based glycerol.          492
  • Table 244. Bio-manufactured Fragrances and Aromatics.               496
  • Table 245. Biotech-derived Fragrance Precursors.                497
  • Table 246. Bio-manufactured Enhancers.  499
  • Table 247. Feedstock Sources for Succinic Acid Production          502
  • Table 248. Applications of Succinic Acid.   502
  • Table 249. Applications of bio-based 1,4-Butanediol (BDO).        502
  • Table 250. Bio-BDO producers.         503
  • Table 251. Feedstock Sources for Isoprene Production.   504
  • Table 252. Applications of Isoprene.              504
  • Table 253. Applications of bio-based ethylene.       505
  • Table 254. Applications of bio-based propylene.   505
  • Table 255. Applications of bio-based adipic acid. 506
  • Table 256. Applications of bio-based acrylic acid.                507
  • Table 257. Applications of sebacic acid       508
  • Table 258. Bio-PBS market analysis-manufacture, advantages, disadvantages and applications.      510
  • Table 259. Leading PBS producers and production capacities.   510
  • Table 260. Polyethylene furanoate (PEF) market analysis-manufacture, advantages, disadvantages and applications.  511
  • Table 261. FDCA and PEF producers.            512
  • Table 262. Polytrimethylene terephthalate (PTT) market analysis-manufacture, advantages, disadvantages and    513
  • Table 263. Production capacities of Polytrimethylene terephthalate (PTT), by leading producers.       514
  • Table 264. Types of Wood-Plastic Composites (WPCs).    516
  • Table 265. Types of Biofiber-Reinforced Plastics.  517
  • Table 266. Types of Polymer Blends with Bio-based Components.           519
  • Table 267. Hyaluronic Acid Production Parameters and Applications     520
  • Table 268. SqualeneSqualane Production Methods and Characteristics.            521
  • Table 269. Collagen Production Systems and Applications.          522
  • Table 270. Bio-based UV Filter Compounds and Characteristics.              523
  • Table 271. Melanin Production and Application Parameters.        524
  • Table 272. Bio-manufactured Emollient Categories and Properties.         525
  • Table 273. Mineral source products and applications.       531
  • Table 274. Cement alternatives from biomanufacturing  534
  • Table 275. Precision Fermentation Products.           535
  • Table 276. Key players in Biochemicals.      536
  • Table 277. Bio-manufactured Beauty Ingredient Production Capacities                539
  • Table 278. Market Growth Drivers and Trends in Biochemicals.  541
  • Table 279. Trends and Drivers in Biotechnology.    542
  • Table 280. Government Support of Biotechnology.              543
  • Table 281. Biochemicals Regulations.          546
  • Table 282. Value chain: Biochemicals.         547
  • Table 283. Economic Viability Assessment Framework.   549
  • Table 284. Feedstock Price Impact Analysis for Biotechnology Production.        550
  • Table 285. Scale-up Cost Impact Analysis.               551
  • Table 286. Addressable market size for Biochemicals.      553
  • Table 287. Risks and Opportunities in Biochemicals.         554
  • Table 288. Market Challenge Assessment and Mitigation Strategies.       555
  • Table 289. Technical Challenge Assessment and Solutions.         556
  • Table 290. Global revenues for biochemicals, by type (2020-2037), billions USD.          556
  • Table 291. Global revenues for biochemicals, by applications market (2020-2037), billions USD.       557
  • Table 292. Global revenues for biochemicals, by regional market (2020-2037), billions USD. 558
  • Table 293. Biochemicals Company Profiles.             560
  • Table 294. Bio-agritech categories. 579
  • Table 295. Biopesticides: Pros and Cons.   580
  • Table 296. Semiochemicals: Advantages and Disadvantages.    581
  • Table 297. Macrobial biological control agents       582
  • Table 298. Biological Pest Control: Advantages and Disadvantages.       582
  • Table 299. Global regulations on biopesticides.     583
  • Table 300. Main types of microbial pesticides.        584
  • Table 301. Main types of biochemical pesticides. 585
  • Table 302. Main types of biofertilizers.          586
  • Table 303. Types of Microbial Biostimulants.           591
  • Table 304. Main types of non-microbial biostimulants.     595
  • Table 305. Types of Agricultural Enzymes   596
  • Table 306. Key players in Bio Agritech.          599
  • Table 307. Market Growth Drivers and Trends in Bio Agritech        600
  • Table 308. Bio Agritech Regulations.              601
  • Table 309. Value chain: Bio Agritech.             602
  • Table 310. Addressable market size for Bio Agritech.          603
  • Table 311. Risks and Opportunities in Bio Agritech.             604
  • Table 312. Global revenues for Bio Agritech products, by applications market (2020-2037), billions USD.                604
  • Table 313. Global revenues for Bio Agritech products, by regional market (2020-2037), billions USD.                606
  • Table 314. Bio agritech Company Profiles. 607

 

List of Figures

  • Figure 1. CRISPR/Cas9 & Targeted Genome Editing.           124
  • Figure 2. Genetic Circuit-Assisted Smart Microbial Engineering. 127
  • Figure 3. Cell-free and cell-based protein synthesis systems.      129
  • Figure 4. Microbial Chassis Development for Natural Product Biosynthesis.     130
  • Figure 5. The design-make-test-learn loop of generative biology.                134
  • Figure 6. Global revenues for biopharmaceuticals, by applications market (2020-2037), billions USD.                154
  • Figure 7. Global revenues for biopharmaceuticals, by regional market (2020-2037), billions USD.     155
  • Figure 8. Global revenues for industrial enzymes, by applications market (2020-2037), billions USD.                213
  • Figure 9. Global revenues for industrial enzymes, by regional market (2020-2037), billions USD.        214
  • Figure 10. Flow chart for biodiesel production.       254
  • Figure 11. Biogas and biomethane pathways.          264
  • Figure 12. Overview of biogas utilization.    266
  • Figure 13. Biogas and biomethane pathways.          268
  • Figure 14. Schematic overview of anaerobic digestion process for biomethane production.   269
  • Figure 15. Schematic overview of biomass gasification for biomethane production.    270
  • Figure 16. Properties of petrol and biobutanol.       275
  • Figure 17. Biobutanol production route.      275
  • Figure 18. Renewable Methanol Production Processes from Different Feedstocks.       285
  • Figure 19. Production of biomethane through anaerobic digestion and upgrading.        286
  • Figure 20. Production of biomethane through biomass gasification and methanation.               287
  • Figure 21. Production of biomethane through the Power to methane process.  287
  • Figure 22. Bio-oil upgrading/fractionation techniques.      293
  • Figure 23. SWOT analysis for Bio-aviation fuel.       301
  • Figure 24. Pathways for algal biomass conversion to biofuels.     305
  • Figure 25. SWOT analysis for algae-derived biofuels.         306
  • Figure 26. Algal biomass conversion process for biofuel production.      307
  • Figure 27. Global revenues for biofuels, by type (2020-2037), billions USD.        322
  • Figure 28. Global Revenues for Biofuels, by Applications Market (2020-2037), billions USD.  323
  • Figure 29. Global revenues for biofuels, by regional market (2020-2037), billions USD.              324
  • Figure 30. PHA family.              368
  • Figure 31. Global revenues for bioplastics, by type (2020-2037), billions USD. 387
  • Figure 32. Global revenues for bioplastics, by applications market (2020-2037), billions USD.             388
  • Figure 33. lobal revenues for bioplastics, by regional market (2020-2037), billions USD.           389
  • Figure 34. Schematic of biorefinery processes.      467
  • Figure 35. Production capacities of PEF and FDCA               512
  • Figure 36. Technology Readiness Level (TRL): Biochemicals.        553
  • Figure 37. Global revenues for biochemicals, by type (2020-2037), billions USD.           557
  • Figure 38. Global revenues for biochemicals, by applications market (2020-2037), billions USD.        558
  • Figure 39. Global revenues for biochemicals, by regional market (2020-2037), billions USD.  559
  • Figure 40. Global revenues for Bio Agritech products, by applications market (2020-2037), billions USD.                605
  • Figure 41. Global revenues for Bio Agritech products, by regional market (2020-2037), billions USD.                606

 

 

 

The Global Industrial Biomanufacturing Market 2027-2037
The Global Industrial Biomanufacturing Market 2027-2037
PDF + Excel.

The Global Industrial Biomanufacturing Market 2027-2037
The Global Industrial Biomanufacturing Market 2027-2037
PDF + Excel + Print Edition (including tracked delivery).

 

Payment methods: Visa, Mastercard, American Express, Bank Transfer. To order by Bank Transfer (Invoice) select this option from the payment methods menu after adding to cart, or contact info@futuremarketsinc.com